World Congress on Precision Biotherapeutics - 2026
The official peer-reviewed open-access journal partner of the World Congress on Precision Biotherapeutics. Publishing high-impact original research, comprehensive reviews, and special thematic proceedings in bioconjugates, RNA therapeutics, gene editing, and precision medicine.
International Peer-Reviewed Open Access Journal • ISSN: 2993-8412
All accepted oral and poster presentation abstracts submitted to WCPB 2026 will be published in the official WCPB 2026 Abstract Supplement of the Journal of Precision Biotherapeutics (JPB), assigned a permanent Digital Object Identifier (DOI), and indexed in online repositories.
Authors of outstanding research presented at WCPB 2026 will be formally invited by the Scientific Committee to submit extended, full-length original research articles or review papers for publication in the special thematic issue: "Frontiers in Precision Biotherapeutics: WCPB 2026 Highlights".
Antibody-drug conjugates, payload chemical kinetics, cleavable linkers, site-specific enzymatic conjugation.
mRNA targeted delivery, siRNA gene silencing, lipid nanoparticle (LNP) formulation, non-viral vector design.
CRISPR-Cas9 gene editing, base/prime editing, CAR-T cell engineering, viral and non-viral delivery vectors.
De novo binder generation, protein structure prediction, target docking algorithms, and machine learning models.
Targeted radionuclide therapy, radiolabeled peptides, PET/SPECT imaging probes, and theranostic pairings.
Liquid biopsy validation, predictive biomarkers, patient stratification assays, and clinical translation protocols.
Submit your full-length research or review manuscript to the Journal of Precision Biotherapeutics (JPB) for peer-review.